Why the study?
Monocyte/high-density lipoprotein ratio is an inflammatory marker associated with vascular diseases, but its relationship with stenosis degree in symptomatic carotid artery stenosis required evaluation.
Is the Monocyte/high-density lipoprotein (HDL) ratio associated with the degree of stenosis in patients with symptomatic carotid artery stenosis?
Is the Monocyte/high-density lipoprotein (HDL) ratio associated with the degree of stenosis in patients with symptomatic carotid artery stenosis?
MHR may support risk stratification for ≥50% symptomatic carotid stenosis; leaves open prospective validation before practice change.
Aim: Monocyte/high-density lipoprotein (HDL) ratio (MHR) is an inflammatory marker associated with vascular diseases. The aim of this study is to evaluate the MHR in patients with symptomatic carotid artery stenosis and to examine its relationship with the degree of stenosis.
No takes yet. Share an insight, caveat, or question.
Eren et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: